OEP PHARMA
DEAD

Serial Number

90318022

Owner

Orient Europharma Co., Ltd.

Attorney

Nicole B. Rackiewicz

Filing Date

Nov 13, 2020

Add to watchlist:

No watchlists yet
View on USPTO

OEP PHARMA Trademark

Serial Number: 90318022

OEP PHARMA is a trademark filed by Orient Europharma Co., Ltd. on November 13, 2020. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

Orient Europharma Co., Ltd. (9 trademarks)

Beitou Dist.,
Taipei City , TW

Entity Type: 03

Trademark Details

Filing Date

November 13, 2020

Registration Date

Not Registered

Published for Opposition

June 15, 2021

Goods & Services

Drug delivery agents in the form of powders that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of tablets that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Pharmaceutical products for the prevention and treatment of cancer; Therapeutic pharmaceuticals for the treatment of cancer, cardiovascular diseases, metabolic diseases, musculoskeletal diseases, infectious diseases, and neurodegenerative diseases; Pharmaceutical preparations for the treatment of hyperlipidemia; Local anesthetics; Drug delivery agents in the form of a coating for tablets and capsules that facilitate the delivery of a wide range of pharmaceuticals; Medicinal preparations of the treatment of infectious diseases and for use in oncology; Anesthetics; Anesthetics for surgical purposes; Pharmaceutical preparations for treating diabetes; Anti-diabetic pharmaceuticals; Cardiovascular agents for medical purposes; Drug delivery agents in the form of transdermal patches, coatings for tablets, and synthetic materials that facilitate the delivery of pharmaceutical preparations; Skeletal muscle relaxants; Pharmaceutical preparations for treating hypertension; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents; Pharmaceutical preparations for the treatment of cancer, cardiovascular diseases, metabolic diseases, musculoskeletal diseases, infectious diseases, and neurodegenerative diseases; Anesthetics for surgical and non-surgical use; Pharmaceuticals, namely, lipid lowering agents; Pharmaceutical preparations for use in chemotherapy; Prescription and non-prescription medicines, namely, pills, tablets, capsules, caplets, liquid drops, sachets and pharmaceutical preparations for the treatment of cardiovascular disorders; Transdermal patches for use in the treatment of neurodegenerative disease; Cardiovascular pharmaceuticals; Hypolipidemic agents; Anesthetics for surgical use; Pain relief medication; Pharmaceutical products for the treatment of cancer; Hypolipidemic agents

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Sep 12, 2022 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Sep 12, 2022 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 1, 2022 EXRA
SOU EXTENSION 1 GRANTED
Jan 28, 2022 EX1G
SOU EXTENSION 1 FILED
Jan 28, 2022 EXT1
SOU TEAS EXTENSION RECEIVED
Jan 28, 2022 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Aug 10, 2021 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 15, 2021 NPUB
PUBLISHED FOR OPPOSITION
Jun 15, 2021 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 26, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
May 10, 2021 CNSA
EXAMINER'S AMENDMENT ENTERED
May 10, 2021 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
May 10, 2021 GNEN
EXAMINERS AMENDMENT E-MAILED
May 10, 2021 GNEA
EXAMINERS AMENDMENT -WRITTEN
May 10, 2021 CNEA
NOTIFICATION OF PRIORITY ACTION E-MAILED
May 3, 2021 GPRN
PRIORITY ACTION E-MAILED
May 3, 2021 GPRA
PRIORITY ACTION WRITTEN
May 3, 2021 CPRA
ASSIGNED TO EXAMINER
Apr 23, 2021 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Jan 14, 2021 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 13, 2021 NWOS
NEW APPLICATION ENTERED
Nov 17, 2020 NWAP